The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Nonvalvular Cardiovascular Device–Related Infections
Open accessAbstract
M ore than a century ago, Osler took numerous syndrome descriptions of cardiac valvular infection that were incomplete and confusing and categorized them into the cardiovascular infections known as infective endocarditis.Because he was both a clinician and a pathologist, he was able to provide a meaningful outline of this complex disease.Technical advances have allowed us to better subcategorize infective endocarditis on the basis of microbiological etiology.More recently, the syndromes of infective endocarditis and endarteritis have been expanded to include infections involving a variety of cardiovascular prostheses and devices that are used to replace or assist damaged or dysfunctional tissues (Table 1).Taken together, infections of these novel intracardiac, arterial, and venous devices are frequently seen in medical centers throughout the developed world.In response, the American Heart Association's Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease wrote this review to assist and educate clinicians who care for an increasing number of patients with nonvalvular cardiovascular device-related infections.Because timely guidelines 1,2 exist that address the prevention and management of intravascular catheter-related infections, these device-related infections are not discussed in the present Statement.This review is divided into two broad sections.The first section examines general principles for the evaluation and management of infection that apply to all nonvalvular cardiovascular devices.Despite the marked variability in composition, structure, function, and frequency of infection among the various types of nonvalvular cardiovascular devices reviewed in this article, there are several areas of commonality for infection of these devices.These include clinical manifestations, microbiology, pathogenesis, diagnosis, treatment, and prevention.The second section addresses each device and describes unique clinical features of infection.Each device is placed into one of 3 categoriesintracardiac, arterial, or venous-for discussion.The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel.Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilm Formation: A Clinically Relevant Microbiological Process
Donlan, R. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322972 · Cited by 1,343
Systemic Infection Related to Endocarditis on Pacemaker Leads: Clinical Presentation and Management
Klug, D., Lacroix, D., Savoye, C., Goullard, L., Grandmougin, D., Hennequin, J. L., Kacet, S., & Lekieffre, J. (1997) · Circulation · doi:10.1161/01.cir.95.8.2098 · Cited by 593
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationClinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591
Wanhainen, A., Verzini, F., Van Herzeele, I., Allaire, E., Bown, M., Cohnert, T., Dick, F., van Herwaarden, J., Karkos, C., Koelemay, M., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.09.020 · Cited by 2,326
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citation
Metadata
- Authors
- Baddour, L. M., Bettmann, M. A., Bolger, A. F., Epstein, A. E., Ferrieri, P., Gerber, M. A., Gewitz, M. H., Jacobs, A. K., Levison, M. E., Newburger, J. W., Pallasch, T. J., Wilson, W. R., Baltimore, R. S., Falace, D. A., Shulman, S. T., Tani, L. Y., & Taubert, K. A.
- Venue
- Circulation
- Published
- 2003-10-21
- Volume
- 108
- Issue
- 16
- Pages
- 2015-2031
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2145109189
- Cited by
- 496
- References
- 2
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonvalvular Cardiovascular Device–Related Infections. https://app.cochat.ai/papers/10.1161/01.cir.0000093201.57771.47
- The paper
- Baddour, L. M., Bettmann, M. A., Bolger, A. F., Epstein, A. E., Ferrieri, P., Gerber, M. A., Gewitz, M. H., Jacobs, A. K., Levison, M. E., Newburger, J. W., Pallasch, T. J., Wilson, W. R., Baltimore, R. S., Falace, D. A., Shulman, S. T., Tani, L. Y., & Taubert, K. A. (2003). Nonvalvular Cardiovascular Device–Related Infections. Circulation. https://doi.org/10.1161/01.cir.0000093201.57771.47
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.